Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.
Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Wei Xu, explained in plain language.
This phase 2 trial tests whether adding golidocitinib to standard chemotherapy and an immunotherapy drug improves outcomes for people with advanced NK/T-cell lymphoma. About 40 adults with newly diagnosed stage III-IV or non-nasal disease will be randomly assigned to receive eith…
Phase: PHASE2 • Sponsor: WEI XU • Aim: Disease control
Last updated May 22, 2026 13:52 UTC